Alterity Therapeutics Ltd

Research Alterity Therapeutics Ltd (ATHE) on Bullrun: market cap USD 88.63M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerATHE
• ExchangeNASDAQ
• CountryAustralia
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 88.63M
• Financial periodQ1 2026
• Free cash flow-USD 4.73M

Valuation Snapshot

latest market cap is USD 88.63M.

About Alterity Therapeutics Ltd

Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage;

Frequently asked questions

What is Alterity Therapeutics Ltd's market cap?

Alterity Therapeutics Ltd's market capitalization is USD 88.63M.

What does Alterity Therapeutics Ltd do?

Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease.